# The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure

> **NCT01942109** · PHASE4 · UNKNOWN · sponsor: **Medical University of Warsaw** · enrollment: 100 (estimated)

## Conditions studied

- Heart Failure

## Interventions

- **DRUG:** Furosemide
- **DRUG:** Torasemide

## Key facts

- **NCT ID:** NCT01942109
- **Lead sponsor:** Medical University of Warsaw
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-09
- **Primary completion:** 2017-12
- **Final completion:** 2018-12
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2017-06-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01942109

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01942109, "The Impact of TORasemide oN hemodynAmic and Neurohormonal Stress, and carDiac remOdeling in Heart Failure". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01942109. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*